Naslov
Well-being and glycemic control in diabetes patients: Baseline data from the cross-national DAWN Monitoring of Individual Needs in Diabetes (MIND) Study

Autori
NOORTJE ZANDBELT, EBBE ELDRUP, JUAN GAGLIARDINO, NORBERT HERMANNS, ANDRZEJ KOKOSZKA, DAVID MATTHEWS, BRIAN MCGUIRE, MIRJANA PIBERNIK- OKANOVIć, JOEL RODRÍGUEZ-SALDAÑ A, SØ REN SKOVLUND, FRANK SNOEK

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Diabetes 57 (Suppl 1) / Butler, Peter C - Alexandria (VA) : American Diabetes Association, 2008

Skup
68th Scientific Sessions of the American Diabetes Association

Mjesto i datum
San Francisco (CA), Sjedinjene Američke Države, 06.06.2008. - 10.06.2008

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
diabetes; emotional well-being; glycemic control; multicentric study

Sažetak
The ongoing cross-national DAWN MIND study aims to promote systematic psychological evaluation in diabetes care to enhance well-being and self- management. The psychological status is assessed at 12 month intervals in diabetes centers across 9 countries, using a computerized, nurse-led procedure assessing demographics, clinical status, well-being (WHO-5), diabetes-distress (PAID), recent life events and the patients’ agenda. The assessment is scheduled prior to the annual review and takes 5-7 minutes. A report on the patient’ s psychological status is automatically generated (scores standardized 0-100) and discussed with the patient. Action is taken if needed (e.g. referral). All diabetes outpatients are eligible if >17 yrs., diabetes duration > 6 months and sufficient language/reading skills. Between Oct 2006 and Dec 2007, 1153 diabetes patients were monitored in 9 countries. Mean age 53.8 yrs. ± 14.8 ; 47.9% male, 63.2% type 2. Overall mean HbA1c was 7.9% ± 1.5 (range 4.5 - 15.7) with no differences by sex or type of diabetes ; 45.2% had ≥ 1 diabetes complication, 55.7% reported ≥ 1 major life event. Mean overall WHO-5 score was 60.3 ± 22.0, between centers range 52.0 - 67.2. Mean PAID also differed across centers (range 15.9 - 35.2) with overall mean of 24.5 ± 19.4. Approximately 1/3 reported reduced well-being (WHO-5 score < 50), range across centers 20.8 - 45.0%, while 1/10 had scores indicative for Depression (WHO-5 score ≤ 28), range 5.3 - 18.1%. One in 5 reported high Diabetes Distress (PAID score ≥ 40), with substantial center differences (range 6.4 - 35.0%). Of all patients, 5.1% (N=59) (range 0.0 - 7.4% across centers) was classified as Depressed-Distressed. Of these, 79.3% (N=46) (range 50 - 100%) were newly identified cases. Those with HbA1c’ s ≥ 8.5% (N=365) had poorer WHO- 5 and PAID scores compared to the rest (p< .05). Patients with complications and/or a major life event also showed poorer psychological functioning (p<.01) warranting attention. The results confirm that monitoring well-being is feasible, without burdening the health care system and helps to identify patients’ psychosocial needs that are otherwise likely to stay unrecognized.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA